{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T21:14:57Z","timestamp":1793999697356,"version":"4.8.0"},"reference-count":163,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T00:00:00Z","timestamp":1707436800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T00:00:00Z","timestamp":1707436800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Endocrinol"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1038\/s41574-023-00948-8","type":"journal-article","created":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T17:02:23Z","timestamp":1707498143000},"page":"278-289","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Consensus guideline for the diagnosis and management of pituitary adenomas in childhood and adolescence: Part\u00a01, general recommendations"],"prefix":"10.1038","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4101-9432","authenticated-orcid":false,"given":"M\u00e1rta","family":"Korbonits","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne C.","family":"Blair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1348-3924","authenticated-orcid":false,"given":"Anna","family":"Boguslawska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Ayuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin H.","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maralyn R.","family":"Druce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Evanson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Flanagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel","family":"Glynn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire E.","family":"Higham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas S.","family":"Jacques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saurabh","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Simmons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicky","family":"Thorp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca M.","family":"Swords","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9963-1931","authenticated-orcid":false,"given":"Helen L.","family":"Storr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen A.","family":"Spoudeas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,9]]},"reference":[{"key":"948_CR1","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1148\/radiology.192.3.8058963","volume":"192","author":"BJ Fisher","year":"1994","unstructured":"Fisher, B. J., Gaspar, L. E., Stitt, L. W. & Noone, B. E. Pituitary adenoma in adolescents: a biologically more aggressive disease? Radiology 192, 869\u2013872 (1994).","journal-title":"Radiology"},{"key":"948_CR2","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1038\/s41574-018-0114-1","volume":"14","author":"A Beckers","year":"2018","unstructured":"Beckers, A., Petrossians, P., Hanson, J. & Daly, A. F. The causes and consequences of pituitary gigantism. Nat. Rev. Endocrinol. 14, 705\u2013720 (2018).","journal-title":"Nat. Rev. Endocrinol."},{"key":"948_CR3","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.ecl.2020.05.005","volume":"49","author":"S Barry","year":"2020","unstructured":"Barry, S. & Korbonits, M. Update on the genetics of pituitary tumors. Endocrinol. Metab. Clin. North Am. 49, 433\u2013452 (2020).","journal-title":"Endocrinol. Metab. Clin. North Am."},{"key":"948_CR4","unstructured":"National Cancer Registration and Analysis Service. Children, Teenagers and Young Adults UK Cancer Statistics Report 2021, Public Health England http:\/\/www.ncin.org.uk\/cancer_type_and_topic_specific_work\/cancer_type_specific_work\/cancer_in_children_teenagers_and_young_adults\/ (2021)."},{"key":"948_CR5","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1007\/s00381-022-05445-3","volume":"38","author":"AP Kelly","year":"2022","unstructured":"Kelly, A. P., Greenfield, J. P., Dobri, G. A. & Schwartz, T. H. Pediatric pituitary adenomas are more aggressive, more likely to be hormone producing and are more difficult to cure than adult pituitary adenomas: case series and systematic literature review. Childs Nerv. Syst. 38, 729\u2013738 (2022).","journal-title":"Childs Nerv. Syst."},{"key":"948_CR6","doi-asserted-by":"publisher","first-page":"304","DOI":"10.4103\/0028-3886.338667","volume":"70","author":"SS Jayant","year":"2022","unstructured":"Jayant, S. S. et al. Paediatric pituitary adenomas: clinical presentation, biochemical profile and long-term prognosis. Neurol. India 70, 304\u2013311 (2022).","journal-title":"Neurol. India"},{"key":"948_CR7","doi-asserted-by":"publisher","first-page":"C5","DOI":"10.1530\/ERC-17-0004","volume":"24","author":"SL Asa","year":"2017","unstructured":"Asa, S. L. et al. From pituitary adenoma to pituitary neuroendocrine tumor (PitNET): an International Pituitary Pathology Club proposal. Endocr. Relat. Cancer 24, C5\u2013C8 (2017).","journal-title":"Endocr. Relat. Cancer"},{"key":"948_CR8","doi-asserted-by":"publisher","first-page":"C7","DOI":"10.1530\/EJE-18-0250","volume":"178","author":"J Trouillas","year":"2018","unstructured":"Trouillas, J. et al. Aggressive pituitary tumours and carcinomas: two sides of the same coin? Eur. J. Endocrinol. 178, C7\u2013C9 (2018).","journal-title":"Eur. J. Endocrinol."},{"key":"948_CR9","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s11102-019-00988-2","volume":"22","author":"KKY Ho","year":"2019","unstructured":"Ho, K. K. Y. et al. A tale of pituitary adenomas: to NET or not to NET: Pituitary Society position statement. Pituitary 22, 569\u2013573 (2019).","journal-title":"Pituitary"},{"key":"948_CR10","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1007\/s11102-019-01027-w","volume":"23","author":"KKY Ho","year":"2020","unstructured":"Ho, K. K. Y. et al. The tale in evolution: clarity, consistency and consultation, not contradiction and confusion. Pituitary 23, 476\u2013477 (2020).","journal-title":"Pituitary"},{"key":"948_CR11","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1007\/s11102-019-01015-0","volume":"23","author":"SL Asa","year":"2020","unstructured":"Asa, S. L. et al. Pituitary neuroendocrine tumors (PitNETs): nomenclature evolution, not clinical revolution. Pituitary 23, 322\u2013325 (2020).","journal-title":"Pituitary"},{"key":"948_CR12","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s12022-022-09703-7","volume":"33","author":"SL Asa","year":"2022","unstructured":"Asa, S. L., Mete, O., Perry, A. & Osamura, R. Y. Overview of the 2022 WHO classification of pituitary tumors. Endocr. Pathol. 33, 6\u201326 (2022).","journal-title":"Endocr. Pathol."},{"key":"948_CR13","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/s41574-023-00883-8","volume":"19","author":"KKY Ho","year":"2023","unstructured":"Ho, K. K. Y. et al. Pituitary adenoma or neuroendocrine tumour: the need for an integrated prognostic classification. Nat. Rev. Endocrinol. 19, 671\u2013678 (2023).","journal-title":"Nat. Rev. Endocrinol."},{"key":"948_CR14","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/s11102-020-01120-5","volume":"24","author":"LE Castellanos","year":"2021","unstructured":"Castellanos, L. E., Misra, M., Smith, T. R., Laws, E. R. & Iorgulescu, J. B. The epidemiology and management patterns of pediatric pituitary tumors in the United States. Pituitary 24, 412\u2013419 (2021).","journal-title":"Pituitary"},{"key":"948_CR15","unstructured":"National Cancer Registration and Analysis Service. Cancer in children, teenagers and young adults, http:\/\/ncin.org.uk\/cancer_type_and_topic_specific_work\/cancer_type_specific_work\/cancer_in_children_teenagers_and_young_adults\/ (Access date:11\/04\/2023)."},{"key":"948_CR16","doi-asserted-by":"publisher","unstructured":"Korbonits, M. et al. Consensus guideline for the diagnosis and management of pituitary adenomas in childhood and adolescence: part 2, specific diseases. Nat. Rev. Endocrinol. https:\/\/doi.org\/10.1038\/s41574-023-00949-7 (2024).","DOI":"10.1038\/s41574-023-00949-7"},{"key":"948_CR17","doi-asserted-by":"publisher","first-page":"E839","DOI":"10.1503\/cmaj.090449","volume":"182","author":"MC Brouwers","year":"2010","unstructured":"Brouwers, M. C. et al. AGREE II: advancing guideline development, reporting and evaluation in health care. Can. Med. Assoc. J. 182, E839\u2013842 (2010).","journal-title":"Can. Med. Assoc. J."},{"key":"948_CR18","unstructured":"Children\u2019s Cancer and Leukaemia Group. Children\u2019s Cancer and Leukaemia Guideline Development Standard Operating Procedure, Version 5 https:\/\/www.cclg.org.uk\/what-we-do\/clinical-treatment-guidelines (Access date: 19\/01\/2022)."},{"key":"948_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6947-7-16","volume":"7","author":"C Schardt","year":"2007","unstructured":"Schardt, C., Adams, M. B., Owens, T., Keitz, S. & Fontelo, P. Utilization of the PICO framework to improve searching PubMed for clinical questions. BMC Med. Inform. Decis. Mak. 7, 16 (2007).","journal-title":"BMC Med. Inform. Decis. Mak."},{"key":"948_CR20","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1136\/bmj.328.7454.1490","volume":"328","author":"D Atkins","year":"2004","unstructured":"Atkins, D. et al. Grading quality of evidence and strength of recommendations. BMJ 328, 1490 (2004).","journal-title":"BMJ"},{"key":"948_CR21","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1055\/s-0038-1625984","volume":"79","author":"A Perry","year":"2018","unstructured":"Perry, A. et al. Pediatric pituitary adenoma: case series, review of the literature, and a skull base treatment paradigm. J. Neurol. Surg. B Skull Base 79, 91\u2013114 (2018).","journal-title":"J. Neurol. Surg. B Skull Base"},{"issue":"Suppl. 1","key":"948_CR22","first-page":"496","volume":"90","author":"K Freund","year":"2018","unstructured":"Freund, K. et al. A 7-year update report of a national, interdisciplinary endeavour to improve outcomes for children and young people under 19 years of age with hypothalamic pituitary axis tumours (HPAT) using multi-site video conferencing. Horm. Res. Paediatr. 90 (Suppl. 1), 496\u2013497 (2018).","journal-title":"Horm. Res. Paediatr."},{"key":"948_CR23","doi-asserted-by":"publisher","first-page":"5134","DOI":"10.1210\/jc.2004-1778","volume":"90","author":"D Batista","year":"2005","unstructured":"Batista, D. et al. Detection of adrenocorticotropin-secreting pituitary adenomas by magnetic resonance imaging in children and adolescents with Cushing disease. J. Clin. Endocrinol. Metab. 90, 5134\u20135140 (2005).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"948_CR24","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1210\/jc.2002-021438","volume":"88","author":"N Patronas","year":"2003","unstructured":"Patronas, N. et al. Spoiled gradient recalled acquisition in the steady state technique is superior to conventional postcontrast spin echo technique for magnetic resonance imaging detection of adrenocorticotropin-secreting pituitary tumors. J. Clin. Endocrinol. Metab. 88, 1565\u20131569 (2003).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"948_CR25","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1111\/j.1365-2265.2009.03646.x","volume":"72","author":"IN Chowdhury","year":"2010","unstructured":"Chowdhury, I. N., Sinaii, N., Oldfield, E. H., Patronas, N. & Nieman, L. K. A change in pituitary magnetic resonance imaging protocol detects ACTH-secreting tumours in patients with previously negative results. Clin. Endocrinol. 72, 502\u2013506 (2010).","journal-title":"Clin. Endocrinol."},{"key":"948_CR26","doi-asserted-by":"publisher","first-page":"129","DOI":"10.2217\/iim.10.16","volume":"2","author":"AS Arbab","year":"2010","unstructured":"Arbab, A. S. 3D gradient echo sequence provides better images in contrast-enhanced imaging of the pituitary gland at 3 T. Imaging Med. 2, 129\u2013130 (2010).","journal-title":"Imaging Med."},{"key":"948_CR27","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.ejrad.2009.12.036","volume":"79","author":"S Kakite","year":"2011","unstructured":"Kakite, S. et al. Three-dimensional gradient echo versus spin echo sequence in contrast-enhanced imaging of the pituitary gland at 3T. Eur. J. Radiol. 79, 108\u2013112 (2011).","journal-title":"Eur. J. Radiol."},{"key":"948_CR28","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1111\/cen.12069","volume":"78","author":"R Kasaliwal","year":"2013","unstructured":"Kasaliwal, R. et al. Volume interpolated 3D-spoiled gradient echo sequence is better than dynamic contrast spin echo sequence for MRI detection of corticotropin secreting pituitary microadenomas. Clin. Endocrinol. 78, 825\u2013830 (2013).","journal-title":"Clin. Endocrinol."},{"key":"948_CR29","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/S2213-8587(23)00162-6","volume":"11","author":"HW Gan","year":"2023","unstructured":"Gan, H. W. et al. National UK guidelines for the management of paediatric craniopharyngioma. Lancet Diabetes Endocrinol. 11, 694\u2013706 (2023).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"948_CR30","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/S2352-4642(21)00088-2","volume":"5","author":"M Cerbone","year":"2021","unstructured":"Cerbone, M. et al. Management of children and young people with idiopathic pituitary stalk thickening, central diabetes insipidus, or both: a national clinical practice consensus guideline. Lancet Child. Adolesc. Health 5, 662\u2013676 (2021).","journal-title":"Lancet Child. Adolesc. Health"},{"key":"948_CR31","doi-asserted-by":"publisher","first-page":"57S","DOI":"10.2967\/jnumed.120.251546","volume":"62","author":"WA Bashari","year":"2021","unstructured":"Bashari, W. A. et al. Using molecular imaging to enhance decision making in the management of pituitary adenomas. J. Nucl. Med. 62, 57S\u201362S (2021).","journal-title":"J. Nucl. Med."},{"key":"948_CR32","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1007\/s00259-021-05458-1","volume":"49","author":"SEM Veldhuijzen van Zanten","year":"2021","unstructured":"Veldhuijzen van Zanten, S. E. M., Neggers, S., Valkema, R. & Verburg, F. A. Positive [18F]fluoroethyltyrosine PET\/MRI in suspected recurrence of growth hormone-producing pituitary adenoma in a paediatric patient. Eur. J. Nucl. Med. Mol. Imaging 49, 410\u2013411 (2021).","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"948_CR33","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.ejrad.2004.08.006","volume":"54","author":"K Pinker","year":"2005","unstructured":"Pinker, K. et al. The value of high-field MRI (3T) in the assessment of sellar lesions. Eur. J. Radiol. 54, 327\u2013334 (2005).","journal-title":"Eur. J. Radiol."},{"key":"948_CR34","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1007\/s00701-012-1285-5","volume":"154","author":"S Berkmann","year":"2012","unstructured":"Berkmann, S., Fandino, J., Muller, B., Remonda, L. & Landolt, H. Intraoperative MRI and endocrinological outcome of transsphenoidal surgery for non-functioning pituitary adenoma. Acta Neurochir. 154, 639\u2013647 (2012).","journal-title":"Acta Neurochir."},{"key":"948_CR35","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1055\/s-0031-1277262","volume":"21","author":"NJ Szerlip","year":"2011","unstructured":"Szerlip, N. J. et al. Transsphenoidal resection of sellar tumors using high-field intraoperative magnetic resonance imaging. Skull Base 21, 223\u2013232 (2011).","journal-title":"Skull Base"},{"key":"948_CR36","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1227\/01.neu.0000243289.98791.05","volume":"59","author":"C Nimsky","year":"2006","unstructured":"Nimsky, C., von Keller, B., Ganslandt, O. & Fahlbusch, R. Intraoperative high-field magnetic resonance imaging in transsphenoidal surgery of hormonally inactive pituitary macroadenomas. Neurosurgery 59, 105\u2013114 (2006).","journal-title":"Neurosurgery"},{"key":"948_CR37","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1227\/01.NEU.0000348549.26832.51","volume":"65","author":"JS Wu","year":"2009","unstructured":"Wu, J. S. et al. Transsphenoidal pituitary macroadenomas resection guided by PoleStar N20 low-field intraoperative magnetic resonance imaging: comparison with early postoperative high-field magnetic resonance imaging. Neurosurgery 65, 63\u201370 (2009).","journal-title":"Neurosurgery"},{"key":"948_CR38","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.clineuro.2014.09.001","volume":"126","author":"E Fomekong","year":"2014","unstructured":"Fomekong, E. et al. Intraoperative 3T MRI for pituitary macroadenoma resection: initial experience in 73 consecutive patients. Clin. Neurol. Neurosurg. 126, 143\u2013149 (2014).","journal-title":"Clin. Neurol. Neurosurg."},{"key":"948_CR39","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.wneu.2017.04.056","volume":"104","author":"H Zhang","year":"2017","unstructured":"Zhang, H. et al. Analysis of 137 patients who underwent endoscopic transsphenoidal pituitary adenoma resection under high-field intraoperative magnetic resonance imaging navigation. World Neurosurg. 104, 802\u2013815 (2017).","journal-title":"World Neurosurg."},{"key":"948_CR40","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1007\/s11102-021-01147-2","volume":"24","author":"VE Staartjes","year":"2021","unstructured":"Staartjes, V. E., Togni-Pogliorini, A., Stumpo, V., Serra, C. & Regli, L. Impact of intraoperative magnetic resonance imaging on gross total resection, extent of resection, and residual tumor volume in pituitary surgery: systematic review and meta-analysis. Pituitary 24, 644\u2013656 (2021).","journal-title":"Pituitary"},{"key":"948_CR41","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1007\/s12098-019-02891-x","volume":"86","author":"S Holowka","year":"2019","unstructured":"Holowka, S., Shroff, M. & Chavhan, G. B. Use and safety of gadolinium based contrast agents in pediatric MR imaging. Indian J. Pediatr. 86, 961\u2013966 (2019).","journal-title":"Indian J. Pediatr."},{"key":"948_CR42","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1007\/s11102-018-0928-9","volume":"22","author":"JF Bonneville","year":"2019","unstructured":"Bonneville, J. F. A plea for the T2W MR sequence for pituitary imaging. Pituitary 22, 195\u2013197 (2019).","journal-title":"Pituitary"},{"key":"948_CR43","doi-asserted-by":"publisher","first-page":"20180746","DOI":"10.1259\/bjr.20180746","volume":"92","author":"R Shah","year":"2019","unstructured":"Shah, R., D\u2019Arco, F., Soares, B., Cooper, J. & Brierley, J. Use of gadolinium contrast agents in paediatric population: Donald Rumsfeld meets hippocrates! Br. J. Radiol. 92, 20180746 (2019).","journal-title":"Br. J. Radiol."},{"key":"948_CR44","doi-asserted-by":"publisher","DOI":"10.1177\/2054358118778573","volume":"5","author":"N Schieda","year":"2018","unstructured":"Schieda, N. et al. Gadolinium-based contrast agents in kidney disease: a comprehensive review and clinical practice guideline issued by the Canadian Association of Radiologists. Can. J. Kidney Health Dis. 5, 2054358118778573 (2018).","journal-title":"Can. J. Kidney Health Dis."},{"key":"948_CR45","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1038\/eye.1997.215","volume":"11","author":"J Suharwardy","year":"1997","unstructured":"Suharwardy, J. & Elston, J. The clinical presentation of children with tumours affecting the anterior visual pathways. Eye 11, 838\u2013844 (1997).","journal-title":"Eye"},{"key":"948_CR46","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1007\/s11060-014-1600-5","volume":"120","author":"E Drimtzias","year":"2014","unstructured":"Drimtzias, E. et al. The ophthalmic natural history of paediatric craniopharyngioma: a long-term review. J. Neurooncol. 120, 651\u2013656 (2014).","journal-title":"J. Neurooncol."},{"key":"948_CR47","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1167\/iovs.12-11385","volume":"54","author":"RA Avery","year":"2013","unstructured":"Avery, R. A., Bouffet, E., Packer, R. J. & Reginald, A. Feasibility and comparison of visual acuity testing methods in children with neurofibromatosis type 1 and\/or optic pathway gliomas. Invest. Ophthalmol. Vis. Sci. 54, 1034\u20131038 (2013).","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"948_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11060-012-0944-y","volume":"110","author":"RA Avery","year":"2012","unstructured":"Avery, R. A. et al. Visual acuity in children with low grade gliomas of the visual pathway: implications for patient care and clinical research. J. Neurooncol. 110, 1\u20137 (2012).","journal-title":"J. Neurooncol."},{"key":"948_CR49","doi-asserted-by":"publisher","first-page":"1804","DOI":"10.1016\/j.ophtha.2007.06.047","volume":"114","author":"RW Beck","year":"2007","unstructured":"Beck, R. W. et al. Visual acuity as an outcome measure in clinical trials of retinal diseases. Ophthalmology 114, 1804\u20131809 (2007).","journal-title":"Ophthalmology"},{"key":"948_CR50","doi-asserted-by":"publisher","unstructured":"Fulton, A. B., Hansen, R., Moskowitz, A. & Mayer, D. In: Pediatric Ophthalmology and Strabismus 4th edn Ch. 4 https:\/\/doi.org\/10.1016\/B978-0-7020-4691-9.00004-2 (2013).","DOI":"10.1016\/B978-0-7020-4691-9.00004-2"},{"key":"948_CR51","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.jcjo.2013.05.001","volume":"48","author":"OY Bialer","year":"2013","unstructured":"Bialer, O. Y., Goldenberg-Cohen, N., Toledano, H., Snir, M. & Michowiz, S. Retinal NFL thinning on OCT correlates with visual field loss in pediatric craniopharyngioma. Can. J. Ophthalmol. 48, 494\u2013499 (2013).","journal-title":"Can. J. Ophthalmol."},{"key":"948_CR52","first-page":"127","volume":"25","author":"SR Rufai","year":"2022","unstructured":"Rufai, S. R. Handheld optical coherence tomography removes barriers to imaging the eyes of young children. Eye 25, 127\u2013143 (2022).","journal-title":"Eye"},{"key":"948_CR53","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/BF01741423","volume":"11","author":"D Wenzel","year":"1988","unstructured":"Wenzel, D., Brandl, U., Beck, J. D., Cedzich, C. & Albert, F. Visual evoked potentials in tumors from orbita to occipital lobe in childhood. Neurosurg. Rev. 11, 279\u2013286 (1988).","journal-title":"Neurosurg. Rev."},{"key":"948_CR54","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/S0161-6420(89)32914-9","volume":"96","author":"MX Repka","year":"1989","unstructured":"Repka, M. X., Miller, N. R. & Miller, M. Visual outcome after surgical removal of craniopharyngiomas. Ophthalmology 96, 195\u2013199 (1989).","journal-title":"Ophthalmology"},{"key":"948_CR55","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/S1091-8531(99)70047-9","volume":"3","author":"KL Stark","year":"1999","unstructured":"Stark, K. L., Kaufman, B., Lee, B. C., Primack, J. & Tychsen, L. Visual recovery after a year of craniopharyngioma-related amaurosis: report of a nine-year-old child and a review of pathophysiologic mechanisms. J. AAPOS 3, 366\u2013371 (1999).","journal-title":"J. AAPOS"},{"key":"948_CR56","doi-asserted-by":"publisher","first-page":"223","DOI":"10.3928\/0191-3913-19970701-09","volume":"34","author":"LS Abrams","year":"1997","unstructured":"Abrams, L. S. & Repka, M. X. Visual outcome of craniopharyngioma in children. J. Pediatr. Ophthalmol. Strabismus 34, 223\u2013228 (1997).","journal-title":"J. Pediatr. Ophthalmol. Strabismus"},{"key":"948_CR57","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1007\/s003810050272","volume":"14","author":"PG Fisher","year":"1998","unstructured":"Fisher, P. G. et al. Outcomes and failure patterns in childhood craniopharyngiomas. Childs Nerv. Syst. 14, 558\u2013563 (1998).","journal-title":"Childs Nerv. Syst."},{"key":"948_CR58","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.ando.2015.04.002","volume":"76","author":"P Chanson","year":"2015","unstructured":"Chanson, P. et al. Management of clinically non-functioning pituitary adenoma. Ann. Endocrinol. 76, 239\u2013247 (2015).","journal-title":"Ann. Endocrinol."},{"key":"948_CR59","unstructured":"Lopes, M. B. et al. in Central Nervous System Tumours in WHO Classification of Tumours Series 5th edn, Vol. 6 (ed Daniel, J. B.) Ch. 12, 406\u2013414 (International Agency for Research on Cancer, 2021)."},{"key":"948_CR60","unstructured":"Lloyd, R. V., Osamura, R. Y., Kloppel, G. & Rosai, J. WHO Classification of Tumours of Endocrine Organs 4th edn (International Agency for Research on Cancer, 2017)."},{"key":"948_CR61","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.ccell.2019.11.002","volume":"37","author":"M Neou","year":"2020","unstructured":"Neou, M. et al. Pangenomic classification of pituitary neuroendocrine tumors. Cancer Cell 37, 123\u2013134 e125 (2020).","journal-title":"Cancer Cell"},{"key":"948_CR62","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s00401-013-1084-y","volume":"126","author":"J Trouillas","year":"2013","unstructured":"Trouillas, J. et al. A new prognostic clinicopathological classification of pituitary adenomas: a multicentric case-control study of 410 patients with 8 years post-operative follow-up. Acta Neuropathol. 126, 123\u2013135 (2013).","journal-title":"Acta Neuropathol."},{"key":"948_CR63","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1093\/jnen\/nlz040","volume":"78","author":"J Chen","year":"2019","unstructured":"Chen, J., Schmidt, R. E. & Dahiya, S. Pituitary adenoma in pediatric and adolescent populations. J. Neuropathol. Exp. Neurol. 78, 626\u2013632 (2019).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"948_CR64","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1007\/s00428-019-02655-0","volume":"475","author":"C Villa","year":"2019","unstructured":"Villa, C. et al. A standardised diagnostic approach to pituitary neuroendocrine tumours (PitNETs): a European Pituitary Pathology Group (EPPG) proposal. Virchows Arch. 475, 687\u2013692 (2019).","journal-title":"Virchows Arch."},{"key":"948_CR65","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1530\/EJE-17-0796","volume":"178","author":"G Raverot","year":"2018","unstructured":"Raverot, G. et al. European Society of Endocrinology Clinical Practice Guidelines for the management of aggressive pituitary tumours and carcinomas. Eur. J. Endocrinol. 178, G1\u2013G24 (2018).","journal-title":"Eur. J. Endocrinol."},{"key":"948_CR66","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/nature26000","volume":"555","author":"D Capper","year":"2018","unstructured":"Capper, D. et al. DNA methylation-based classification of central nervous system tumours. Nature 555, 469\u2013474 (2018).","journal-title":"Nature"},{"key":"948_CR67","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1126\/science.1126100","volume":"312","author":"O Vierimaa","year":"2006","unstructured":"Vierimaa, O. et al. Pituitary adenoma predisposition caused by germline mutations in the AIP gene. Science 312, 1228\u20131230 (2006).","journal-title":"Science"},{"key":"948_CR68","doi-asserted-by":"publisher","first-page":"2363","DOI":"10.1056\/NEJMoa1408028","volume":"371","author":"G Trivellin","year":"2014","unstructured":"Trivellin, G. et al. Gigantism and acromegaly due to Xq26 microduplications and GPR101 mutation. N. Engl. J. Med. 371, 2363\u20132374 (2014).","journal-title":"N. Engl. J. Med."},{"key":"948_CR69","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1159\/000357673","volume":"81","author":"F Guaraldi","year":"2014","unstructured":"Guaraldi, F., Storr, H. L., Ghizzoni, L., Ghigo, E. & Savage, M. O. Paediatric pituitary adenomas: a decade of change. Horm. Res. Paediatr. 81, 145\u2013155 (2014).","journal-title":"Horm. Res. Paediatr."},{"key":"948_CR70","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.ghir.2016.08.002","volume":"30-31","author":"F Hannah-Shmouni","year":"2016","unstructured":"Hannah-Shmouni, F., Trivellin, G. & Stratakis, C. A. Genetics of gigantism and acromegaly. Growth Horm. IGF Res. 30-31, 37\u201341 (2016).","journal-title":"Growth Horm. IGF Res."},{"key":"948_CR71","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1007\/s12020-021-02633-0","volume":"71","author":"J Denes","year":"2021","unstructured":"Denes, J. & Korbonits, M. The clinical aspects of pituitary tumour genetics. Endocrine 71, 663\u2013674 (2021).","journal-title":"Endocrine"},{"key":"948_CR72","doi-asserted-by":"publisher","first-page":"E373","DOI":"10.1210\/jc.2009-2556","volume":"95","author":"AF Daly","year":"2010","unstructured":"Daly, A. F. et al. Clinical characteristics and therapeutic responses in patients with germ-line AIP mutations and pituitary adenomas: an international collaborative study. J. Clin. Endocrinol. Metab. 95, E373\u2013E383 (2010).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"948_CR73","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1210\/jc.2014-3659","volume":"100","author":"P Goudet","year":"2015","unstructured":"Goudet, P. et al. MEN1 disease occurring before 21 years old: a 160-patient cohort study from the Groupe d\u2019etude des Tumeurs Endocrines. J. Clin. Endocrinol. Metab. 100, 1568\u20131577 (2015).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"948_CR74","doi-asserted-by":"publisher","first-page":"e2247","DOI":"10.1210\/clinem\/dgaa040","volume":"105","author":"P Marques","year":"2020","unstructured":"Marques, P. et al. Significant benefits of AIP testing and clinical screening in familial isolated and young-onset pituitary tumors. J. Clin. Endocrinol. Metab. 105, e2247\u20132260 (2020).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"948_CR75","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1210\/jc.2013-3826","volume":"99","author":"S Salenave","year":"2014","unstructured":"Salenave, S., Boyce, A. M., Collins, M. T. & Chanson, P. Acromegaly and McCune-Albright syndrome. J. Clin. Endocrinol. Metab. 99, 1955\u20131969 (2014).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"948_CR76","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1210\/jc.2015-4366","volume":"101","author":"C Rodd","year":"2016","unstructured":"Rodd, C. et al. Somatic GPR101 duplication causing X-Linked acrogigantism (XLAG)-diagnosis and management. J. Clin. Endocrinol. Metab. 101, 1927\u20131930 (2016).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"948_CR77","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1111\/j.1365-2265.2012.04445.x","volume":"77","author":"M Korbonits","year":"2012","unstructured":"Korbonits, M., Storr, H. & Kumar, A. V. Familial pituitary adenomas \u2014 who should be tested for AIP mutations? Clin. Endocrinol. 77, 351\u2013356 (2012).","journal-title":"Clin. Endocrinol."},{"key":"948_CR78","doi-asserted-by":"publisher","first-page":"2990","DOI":"10.1210\/jc.2012-1230","volume":"97","author":"RV Thakker","year":"2012","unstructured":"Thakker, R. V. et al. Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1). J. Clin. Endocrinol. Metab. 97, 2990\u20133011 (2012).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"948_CR79","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1530\/ERC-15-0320","volume":"22","author":"L Rostomyan","year":"2015","unstructured":"Rostomyan, L. et al. Clinical and genetic characterization of pituitary gigantism: an international collaborative study in 208 patients. Endocr. Relat. Cancer 22, 745\u2013757 (2015).","journal-title":"Endocr. Relat. Cancer"},{"key":"948_CR80","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s40478-016-0328-1","volume":"4","author":"D Iacovazzo","year":"2016","unstructured":"Iacovazzo, D. et al. Germline or somatic GPR101 duplication leads to X-linked acrogigantism: a clinico-pathological and genetic study. Acta Neuropathol. Commun. 4, 56 (2016).","journal-title":"Acta Neuropathol. Commun."},{"key":"948_CR81","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.ajhg.2022.02.002","volume":"109","author":"M Franke","year":"2022","unstructured":"Franke, M. et al. Duplications disrupt chromatin architecture and rewire GPR101-enhancer communication in X-linked acrogigantism. Am. J. Hum. Genet. 109, 553\u2013570 (2022).","journal-title":"Am. J. Hum. Genet."},{"key":"948_CR82","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1515\/JPEM.1999.12.3.381","volume":"12","author":"MC Johnson","year":"1999","unstructured":"Johnson, M. C. et al. Gps mutations in Chilean patients harboring growth hormone-secreting pituitary tumors. J. Pediatr. Endocrinol. Metab. 12, 381\u2013387 (1999).","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"948_CR83","doi-asserted-by":"publisher","first-page":"E1242","DOI":"10.1210\/jc.2015-1869","volume":"100","author":"LC Hernandez-Ramirez","year":"2015","unstructured":"Hernandez-Ramirez, L. C. et al. Landscape of familial isolated and young-onset pituitary adenomas: prospective diagnosis in AIP mutation carriers. J. Clin. Endocrinol. Metab. 100, E1242\u2013E1254 (2015).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"948_CR84","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1507\/endocrj.EJ18-0370","volume":"66","author":"D Watanabe","year":"2019","unstructured":"Watanabe, D. et al. GH\/PRL-secreting pituitary macroadenoma associated with GNAS p.Gln227Leu mutation: pediatric case report and review. Endocr. J. 66, 403\u2013408 (2019).","journal-title":"Endocr. J."},{"key":"948_CR85","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1530\/EJE-12-0763","volume":"168","author":"T Cuny","year":"2013","unstructured":"Cuny, T. et al. Genetic analysis in young patients with sporadic pituitary macroadenomas: besides AIP don\u2019t forget MEN1 genetic analysis. Eur. J. Endocrinol. 168, 533\u2013541 (2013).","journal-title":"Eur. J. Endocrinol."},{"key":"948_CR86","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1210\/jc.2014-3670","volume":"100","author":"S Salenave","year":"2015","unstructured":"Salenave, S. et al. Macroprolactinomas in children and adolescents: factors associated with the response to treatment in 77 patients. J. Clin. Endocrinol. Metab. 100, 1177\u20131186 (2015).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"948_CR87","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1210\/clinem\/dgaa957","volume":"106","author":"AJ Seabrook","year":"2021","unstructured":"Seabrook, A. J. et al. Multiple endocrine tumors associated with germline MAX mutations: multiple endocrine neoplasia type 5? J. Clin. Endocrinol. Metab. 106, 1163\u20131182 (2021).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"948_CR88","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1056\/NEJMoa1805171","volume":"379","author":"T Kobayashi","year":"2018","unstructured":"Kobayashi, T., Usui, H., Tanaka, H. & Shozu, M. Variant prolactin receptor in agalactia and hyperprolactinemia. N. Engl. J. Med. 379, 2230\u20132236 (2018).","journal-title":"N. Engl. J. Med."},{"key":"948_CR89","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1056\/NEJMoa1307557","volume":"369","author":"PJ Newey","year":"2013","unstructured":"Newey, P. J. et al. Mutant prolactin receptor and familial hyperprolactinemia. N. Engl. J. Med. 369, 2012\u20132020 (2013).","journal-title":"N. Engl. J. Med."},{"key":"948_CR90","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1210\/clinem\/dgaa160","volume":"105","author":"F Chasseloup","year":"2020","unstructured":"Chasseloup, F. et al. Germline CDKN1B loss-of-function variants cause pediatric Cushing\u2019s disease with or without an MEN4 phenotype. J. Clin. Endocrinol. Metab. 105, 1983\u20132005 (2020).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"948_CR91","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1530\/eje.0.1510709","volume":"151","author":"M Rix","year":"2004","unstructured":"Rix, M. et al. Cushing\u2019s disease in childhood as the first manifestation of multiple endocrine neoplasia syndrome type 1. Eur. J. Endocrinol. 151, 709\u2013715 (2004).","journal-title":"Eur. J. Endocrinol."},{"key":"948_CR92","first-page":"4776","volume":"85","author":"CA Stratakis","year":"2000","unstructured":"Stratakis, C. A. et al. Pituitary macroadenoma in a 5-year-old: an early expression of multiple endocrine neoplasia type 1. J. Clin. Endocrinol. Metab. 85, 4776\u20134780 (2000).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"948_CR93","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1530\/ERC-17-0131","volume":"24","author":"LC Hernandez-Ramirez","year":"2017","unstructured":"Hernandez-Ramirez, L. C. et al. Loss-of-function mutations in the CABLES1 gene are a novel cause of Cushing\u2019s disease. Endocr. Relat. Cancer 24, 379\u2013392 (2017).","journal-title":"Endocr. Relat. Cancer"},{"key":"948_CR94","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s00401-014-1285-z","volume":"128","author":"L de Kock","year":"2014","unstructured":"de Kock, L. et al. Pituitary blastoma: a pathognomonic feature of germ-line DICER1 mutations. Acta Neuropathol. 128, 111\u2013122 (2014).","journal-title":"Acta Neuropathol."},{"key":"948_CR95","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1210\/clinem\/dgaa857","volume":"106","author":"APY Liu","year":"2021","unstructured":"Liu, A. P. Y. et al. Clinical outcomes and complications of pituitary blastoma. J. Clin. Endocrinol. Metab. 106, 351\u2013363 (2021).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"948_CR96","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.wneu.2020.04.096","volume":"139","author":"Y Chhuon","year":"2020","unstructured":"Chhuon, Y. et al. Pituitary blastoma in a 19-year-old woman: a case report and review of literature. World Neurosurg. 139, 310\u2013313 (2020).","journal-title":"World Neurosurg."},{"key":"948_CR97","first-page":"969","volume":"32","author":"AS Chong","year":"2021","unstructured":"Chong, A. S. et al. DICER1 syndrome in a young adult with pituitary blastoma. Acta Neuropathol. 32, 969\u2013977 (2021).","journal-title":"Acta Neuropathol."},{"key":"948_CR98","doi-asserted-by":"publisher","first-page":"2836","DOI":"10.1210\/jc.2017-00161","volume":"102","author":"FR Faucz","year":"2017","unstructured":"Faucz, F. R. et al. Somatic USP8 gene mutations are a common cause of pediatric Cushing disease. J. Clin. Endocrinol. Metab. 102, 2836\u20132843 (2017).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"948_CR99","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/ng.3166","volume":"47","author":"M Reincke","year":"2015","unstructured":"Reincke, M. et al. Mutations in the deubiquitinase gene USP8 cause Cushing\u2019s disease. Nat. Genet. 47, 31\u201338 (2015).","journal-title":"Nat. Genet."},{"key":"948_CR100","doi-asserted-by":"publisher","first-page":"E997","DOI":"10.1210\/jc.2015-1453","volume":"100","author":"LG Perez-Rivas","year":"2015","unstructured":"Perez-Rivas, L. G. et al. The gene of the ubiquitin-specific protease 8 is frequently mutated in adenomas causing cushing\u2019s disease. J. Clin. Endocrinol. Metab. 100, E997\u20131004, (2015).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"948_CR101","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/cr.2015.20","volume":"25","author":"ZY Ma","year":"2015","unstructured":"Ma, Z. Y. et al. Recurrent gain-of-function USP8 mutations in Cushing\u2019s disease. Cell Res. 25, 306\u2013317 (2015).","journal-title":"Cell Res."},{"key":"948_CR102","doi-asserted-by":"publisher","first-page":"4676","DOI":"10.1210\/jc.2019-00697","volume":"104","author":"M Cohen","year":"2019","unstructured":"Cohen, M. et al. Germline USP8 mutation associated with pediatric Cushing disease and other clinical features: a new syndrome. J. Clin. Endocrinol. Metab. 104, 4676\u20134682 (2019).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"948_CR103","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1210\/jc.2018-02164","volume":"104","author":"C Tatsi","year":"2019","unstructured":"Tatsi, C. et al. Large genomic aberrations in corticotropinomas are associated with greater aggressiveness. J. Clin. Endocrinol. Metab. 104, 1792\u20131801 (2019).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"948_CR104","doi-asserted-by":"publisher","first-page":"2511","DOI":"10.1210\/jc.2014-3994","volume":"100","author":"X Teng","year":"2015","unstructured":"Teng, X. et al. A patient with a thyrotropin-secreting microadenoma and resistance to thyroid hormone (P453T). J. Clin. Endocrinol. Metab. 100, 2511\u20132514 (2015).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"948_CR105","unstructured":"Wass, J. A. H. & Lansdown, M. Endocrinology, Getting It Right First Time (GIRFT) Programme National Specialty Report https:\/\/www.gettingitrightfirsttime.co.uk\/wp-content\/uploads\/2021\/08\/EndocrinologyReport-Aug21o-NEW.pdf (2021)."},{"key":"948_CR106","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1007\/s11102-018-0912-4","volume":"21","author":"FF Casanueva","year":"2018","unstructured":"Casanueva, F. F. et al. Correction to: criteria for the definition of pituitary tumor centers of excellence (PTCOE): a pituitary society statement. Pituitary 21, 663 (2018).","journal-title":"Pituitary"},{"key":"948_CR107","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/s11102-018-0904-4","volume":"21","author":"J Honegger","year":"2018","unstructured":"Honegger, J. & Grimm, F. The experience with transsphenoidal surgery and its importance to outcomes. Pituitary 21, 545\u2013555 (2018).","journal-title":"Pituitary"},{"key":"948_CR108","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.jocn.2004.10.003","volume":"12","author":"P Pandey","year":"2005","unstructured":"Pandey, P., Ojha, B. K. & Mahapatra, A. K. Pediatric pituitary adenoma: a series of 42 patients. J. Clin. Neurosci. 12, 124\u2013127 (2005).","journal-title":"J. Clin. Neurosci."},{"key":"948_CR109","first-page":"413","volume":"103","author":"AS Kanter","year":"2005","unstructured":"Kanter, A. S. et al. Single-center experience with pediatric Cushing\u2019s disease. J. Neurosurg. 103, 413\u2013420 (2005).","journal-title":"J. Neurosurg."},{"key":"948_CR110","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1227\/01.NEU.0000166580.94215.53","volume":"57","author":"SM Joshi","year":"2005","unstructured":"Joshi, S. M. et al. Cushing\u2019s disease in children and adolescents: 20 years of experience in a single neurosurgical center. Neurosurgery 57, 281\u2013285 (2005).","journal-title":"Neurosurgery"},{"key":"948_CR111","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1007\/s00431-014-2427-y","volume":"174","author":"A Gkourogianni","year":"2015","unstructured":"Gkourogianni, A. et al. Death in pediatric Cushing syndrome is uncommon but still occurs. Eur. J. Pediatr. 174, 501\u2013507 (2015).","journal-title":"Eur. J. Pediatr."},{"key":"948_CR112","doi-asserted-by":"publisher","first-page":"106411","DOI":"10.1016\/j.clineuro.2020.106411","volume":"200","author":"S Dhandapani","year":"2021","unstructured":"Dhandapani, S. et al. Endonasal endoscopic versus microscopic transsphenoidal surgery in pituitary tumors among the young: a comparative study & meta-analysis. Clin. Neurol. Neurosurg. 200, 106411 (2021).","journal-title":"Clin. Neurol. Neurosurg."},{"key":"948_CR113","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1227\/00006123-199402000-00001","volume":"34","author":"EH Dyer","year":"1994","unstructured":"Dyer, E. H., Civit, T., Visot, A., Delalande, O. & Derome, P. Transsphenoidal surgery for pituitary adenomas in children. Neurosurgery 34, 207\u2013212 (1994).","journal-title":"Neurosurgery"},{"key":"948_CR114","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.jpeds.2017.11.042","volume":"195","author":"C Saldarriaga","year":"2018","unstructured":"Saldarriaga, C. et al. Postoperative diabetes insipidus and hyponatremia in children after transsphenoidal surgery for adrenocorticotropin hormone and growth hormone secreting adenomas. J. Pediatr. 195, 169\u2013174.e1 (2018).","journal-title":"J. Pediatr."},{"key":"948_CR115","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1007\/s00381-019-04258-1","volume":"35","author":"C Koumas","year":"2019","unstructured":"Koumas, C. et al. Outcomes following endoscopic endonasal resection of sellar and supresellar lesions in pediatric patients. Childs Nerv. Syst. 35, 2099\u20132105 (2019).","journal-title":"Childs Nerv. Syst."},{"key":"948_CR116","doi-asserted-by":"publisher","first-page":"e15","DOI":"10.1016\/j.endonu.2014.01.005","volume":"61","author":"C Lamas","year":"2014","unstructured":"Lamas, C., del Pozo, C. & Villabona, C., Neuroendocrinology Group of the SEEN. Clinical guidelines for management of diabetes insipidus and syndrome of inappropriate antidiuretic hormone secretion after pituitary surgery. Endocrinol. Nutr. 61, e15\u2013e24 (2014).","journal-title":"Endocrinol. Nutr."},{"key":"948_CR117","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1007\/s11102-020-01083-7","volume":"24","author":"F de Vries","year":"2021","unstructured":"de Vries, F. et al. Postoperative diabetes insipidus: how to define and grade this complication? Pituitary 24, 284\u2013291 (2021).","journal-title":"Pituitary"},{"key":"948_CR118","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/j.1365-2265.2010.03913.x","volume":"74","author":"S Rajasekaran","year":"2011","unstructured":"Rajasekaran, S. et al. UK guidelines for the management of pituitary apoplexy. Clin. Endocrinol. 74, 9\u201320 (2011).","journal-title":"Clin. Endocrinol."},{"key":"948_CR119","doi-asserted-by":"publisher","first-page":"162","DOI":"10.5152\/TurkPediatriArs.2016.1945","volume":"51","author":"M Ozcetin","year":"2016","unstructured":"Ozcetin, M., Karaci, M., Toroslu, E. & Edebali, N. A pediatric case of pituitary macroadenoma presenting with pituitary apoplexy and cranial nerve involvement: case report. Turk. Pediatr. Ars 51, 162\u2013165 (2016).","journal-title":"Turk. Pediatr. Ars"},{"key":"948_CR120","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1530\/ERC-11-0059","volume":"18","author":"C Villa","year":"2011","unstructured":"Villa, C. et al. Hyperplasia-adenoma sequence in pituitary tumorigenesis related to aryl hydrocarbon receptor interacting protein (AIP) gene mutation. Endocr. Relat. Cancer 18, 347\u2013356 (2011).","journal-title":"Endocr. Relat. Cancer"},{"key":"948_CR121","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1210\/jc.2013-2868","volume":"99","author":"F Williams","year":"2014","unstructured":"Williams, F. et al. Clinical experience in the screening and management of a large kindred with familial isolated pituitary adenoma due to an aryl hydrocarbon receptor interacting protein (AIP) mutation. J. Clin. Endocrinol. Metab. 99, 1122\u20131131 (2014).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"948_CR122","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.pediatrneurol.2014.02.004","volume":"50","author":"CC Chao","year":"2014","unstructured":"Chao, C. C. & Lin, C. J. Pituitary apoplexy in a teenager-case report. Pediatr. Neurol. 50, 648\u2013651 (2014).","journal-title":"Pediatr. Neurol."},{"key":"948_CR123","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1007\/s11102-018-0900-8","volume":"21","author":"E Culpin","year":"2018","unstructured":"Culpin, E. et al. Pituitary tumour apoplexy within prolactinomas in children: a more aggressive condition? Pituitary 21, 474\u2013479 (2018).","journal-title":"Pituitary"},{"key":"948_CR124","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1007\/s00381-019-04167-3","volume":"35","author":"CE Deopujari","year":"2019","unstructured":"Deopujari, C. E., Shah, N. J., Shaikh, S. T., Karmarkar, V. S. & Mohanty, C. B. Endonasal endoscopic skullbase surgery in children. Childs Nerv. Syst. 35, 2091\u20132098 (2019).","journal-title":"Childs Nerv. Syst."},{"key":"948_CR125","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1111\/cen.12275","volume":"80","author":"HL Storr","year":"2014","unstructured":"Storr, H. L. et al. Endonasal endoscopic transsphenoidal pituitary surgery: early experience and outcome in paediatric Cushing\u2019s disease. Clin. Endocrinol. 80, 270\u2013276 (2014).","journal-title":"Clin. Endocrinol."},{"key":"948_CR126","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1055\/a-1373-4087","volume":"129","author":"T Deutschbein","year":"2021","unstructured":"Deutschbein, T. et al. First German guideline on diagnostics and therapy of clinically non-functioning pituitary tumors. Exp. Clin. Endocrinol. Diabetes 129, 250\u2013264 (2021).","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"948_CR127","doi-asserted-by":"publisher","first-page":"227","DOI":"10.3171\/2012.10.PEDS12160","volume":"11","author":"S Chivukula","year":"2013","unstructured":"Chivukula, S. et al. Endoscopic endonasal skull base surgery in the pediatric population. J. Neurosurg. Pediatr. 11, 227\u2013241 (2013).","journal-title":"J. Neurosurg. Pediatr."},{"key":"948_CR128","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1007\/s00701-010-0929-6","volume":"153","author":"L Massimi","year":"2011","unstructured":"Massimi, L. et al. Quality of postoperative course in children: endoscopic endonasal surgery versus sublabial microsurgery. Acta Neurochir. 153, 843\u2013849 (2011).","journal-title":"Acta Neurochir."},{"key":"948_CR129","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1507\/endocrj.K10E-352","volume":"58","author":"Y Kinoshita","year":"2011","unstructured":"Kinoshita, Y. et al. Post-operative hyponatremia in patients with pituitary adenoma: post-operative management with a uniform treatment protocol. Endocr. J. 58, 373\u2013379 (2011).","journal-title":"Endocr. J."},{"key":"948_CR130","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1097\/00000421-198812000-00001","volume":"11","author":"PW Grigsby","year":"1988","unstructured":"Grigsby, P. W., Thomas, P. R., Simpson, J. R. & Fineberg, B. B. Long-term results of radiotherapy in the treatment of pituitary adenomas in children and adolescents. Am. J. Clin. Oncol. 11, 607\u2013611 (1988).","journal-title":"Am. J. Clin. Oncol."},{"key":"948_CR131","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3171\/jns.1994.80.2.0209","volume":"80","author":"MD Partington","year":"1994","unstructured":"Partington, M. D., Davis, D. H., Laws, E. R. Jr. & Scheithauer, B. W. Pituitary adenomas in childhood and adolescence. Results of transsphenoidal surgery. J. Neurosurg. 80, 209\u2013216 (1994).","journal-title":"J. Neurosurg."},{"key":"948_CR132","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1007\/BF03343820","volume":"24","author":"E De Menis","year":"2001","unstructured":"De Menis, E. et al. Pituitary adenomas in childhood and adolescence. Clinical analysis of 10 cases. J. Endocrinol. Invest. 24, 92\u201397 (2001).","journal-title":"J. Endocrinol. Invest."},{"key":"948_CR133","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s00381-006-0259-4","volume":"23","author":"M Mehrazin","year":"2007","unstructured":"Mehrazin, M. Pituitary tumors in children: clinical analysis of 21 cases. Childs Nerv. Syst. 23, 391\u2013398 (2007).","journal-title":"Childs Nerv. Syst."},{"key":"948_CR134","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/j.ijrobp.2006.09.049","volume":"67","author":"AC van den Bergh","year":"2007","unstructured":"van den Bergh, A. C. et al. Immediate postoperative radiotherapy in residual nonfunctioning pituitary adenoma: beneficial effect on local control without additional negative impact on pituitary function and life expectancy. Int. J. Radiat. Oncol. Biol. Phys. 67, 863\u2013869 (2007).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"948_CR135","doi-asserted-by":"publisher","first-page":"736","DOI":"10.3171\/JNS\/2008\/108\/4\/0736","volume":"108","author":"EF Chang","year":"2008","unstructured":"Chang, E. F. et al. Long-term recurrence and mortality after surgery and adjuvant radiotherapy for nonfunctional pituitary adenomas. J. Neurosurg. 108, 736\u2013745 (2008).","journal-title":"J. Neurosurg."},{"key":"948_CR136","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1056\/NEJM197711032971801","volume":"297","author":"AS Jennings","year":"1977","unstructured":"Jennings, A. S., Liddle, G. W. & Orth, D. N. Results of treating childhood Cushing\u2019s disease with pituitary irradiation. N. Engl. J. Med. 297, 957\u2013962 (1977).","journal-title":"N. Engl. J. Med."},{"key":"948_CR137","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1007\/s11102-016-0756-8","volume":"19","author":"G Yordanova","year":"2016","unstructured":"Yordanova, G. et al. Long-term outcomes of children treated for Cushing\u2019s disease: a single center experience. Pituitary 19, 612\u2013624 (2016).","journal-title":"Pituitary"},{"key":"948_CR138","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1007\/s00381-010-1129-7","volume":"26","author":"MF Fraioli","year":"2010","unstructured":"Fraioli, M. F., Novegno, F., Catena, E., Fraioli, C. & Moschettoni, L. Multidisciplinary treatment of giant invasive prolactinomas in paediatric age: long-term follow-up in two children. Childs Nerv. Syst. 26, 1233\u20131237 (2010).","journal-title":"Childs Nerv. Syst."},{"key":"948_CR139","doi-asserted-by":"publisher","first-page":"e1104","DOI":"10.1016\/j.wneu.2019.01.252","volume":"125","author":"A Shrivastava","year":"2019","unstructured":"Shrivastava, A. et al. Outcomes after gamma knife stereotactic radiosurgery in pediatric patients with Cushing disease or acromegaly: a multi-institutional study. World Neurosurg. 125, e1104\u2013e1113 (2019).","journal-title":"World Neurosurg."},{"key":"948_CR140","doi-asserted-by":"publisher","first-page":"202","DOI":"10.3171\/2015.5.JNS15581","volume":"125","author":"IJ Pomeraniec","year":"2016","unstructured":"Pomeraniec, I. J., Dallapiazza, R. F., Xu, Z., Jane, J. A. Jr. & Sheehan, J. P. Early versus late Gamma Knife radiosurgery following transsphenoidal resection for nonfunctioning pituitary macroadenomas: a matched cohort study. J. Neurosurg. 125, 202\u2013212 (2016).","journal-title":"J. Neurosurg."},{"key":"948_CR141","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1046\/j.1365-2265.2000.00967.x","volume":"52","author":"R Jalali","year":"2000","unstructured":"Jalali, R. et al. Stereotactic conformal radiotherapy for pituitary adenomas: technique and preliminary experience. Clin. Endocrinol. 52, 695\u2013702 (2000).","journal-title":"Clin. Endocrinol."},{"key":"948_CR142","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.ijrobp.2004.09.058","volume":"62","author":"P Colin","year":"2005","unstructured":"Colin, P. et al. Treatment of pituitary adenomas by fractionated stereotactic radiotherapy: a prospective study of 110 patients. Int. J. Radiat. Oncol. Biol. Phys. 62, 333\u2013341 (2005).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"948_CR143","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.ijrobp.2006.08.039","volume":"67","author":"HB Mackley","year":"2007","unstructured":"Mackley, H. B. et al. Intensity-modulated radiotherapy for pituitary adenomas: the preliminary report of the Cleveland Clinic experience. Int. J. Radiat. Oncol. Biol. Phys. 67, 232\u2013239 (2007).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"948_CR144","doi-asserted-by":"publisher","first-page":"286","DOI":"10.3747\/co.v15i6.293","volume":"15","author":"H Elhateer","year":"2008","unstructured":"Elhateer, H. et al. Fractionated stereotactic radiotherapy in the treatment of pituitary macroadenomas. Curr. Oncol. 15, 286\u2013292 (2008).","journal-title":"Curr. Oncol."},{"key":"948_CR145","unstructured":"Arauz, R. & Rodriguez, M. In: 19th Annual Scientific Meeting of the Society for Neuro-Oncology (Oxford Journals, 2015)."},{"key":"948_CR146","unstructured":"Almeldin, D. et al. Radiotherapy for Pituitary Tumors. ENDOTEXT. https:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25905190 (2023)."},{"key":"948_CR147","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1210\/jc.2002-021032","volume":"88","author":"HL Storr","year":"2003","unstructured":"Storr, H. L. et al. Clinical and endocrine responses to pituitary radiotherapy in pediatric Cushing\u2019s disease: an effective second-line treatment. J. Clin. Endocrinol. Metab. 88, 34\u201337 (2003).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"948_CR148","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.ijrobp.2005.07.978","volume":"64","author":"BB Ronson","year":"2006","unstructured":"Ronson, B. B. et al. Fractionated proton beam irradiation of pituitary adenomas. Int. J. Radiat. Oncol. Biol. Phys. 64, 425\u2013434 (2006).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"948_CR149","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1002\/pbc.21530","volume":"51","author":"TE Merchant","year":"2008","unstructured":"Merchant, T. E. et al. Proton versus photon radiotherapy for common pediatric brain tumors: comparison of models of dose characteristics and their relationship to cognitive function. Pediatr. Blood Cancer 51, 110\u2013117 (2008).","journal-title":"Pediatr. Blood Cancer"},{"key":"948_CR150","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.3109\/0284186X.2013.818255","volume":"52","author":"SE Combs","year":"2013","unstructured":"Combs, S. E. et al. Proton and carbon ion radiotherapy for primary brain tumors and tumors of the skull base. Acta Oncol. 52, 1504\u20131509 (2013).","journal-title":"Acta Oncol."},{"key":"948_CR151","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1046\/j.1365-2265.1999.00854.x","volume":"51","author":"PN Plowman","year":"1999","unstructured":"Plowman, P. N. Pituitary adenoma radiotherapy-when, who and how? Clin. Endocrinol. 51, 265\u2013271 (1999).","journal-title":"Clin. Endocrinol."},{"key":"948_CR152","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.1210\/jc.2011-0251","volume":"96","author":"JS Loeffler","year":"2011","unstructured":"Loeffler, J. S. & Shih, H. A. Radiation therapy in the management of pituitary adenomas. J. Clin. Endocrinol. Metab. 96, 1992\u20132003 (2011).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"948_CR153","doi-asserted-by":"publisher","first-page":"S33","DOI":"10.1016\/j.ijrobp.2006.05.076","volume":"66","author":"GG Grabenbauer","year":"2006","unstructured":"Grabenbauer, G. G., Ernst-Stecken, A., Schneider, F., Lambrecht, U. & Ganslandt, O. Radiosurgery of functioning pituitary adenomas: comparison of different treatment techniques including dynamic and conformal arcs, shaped beams, and IMRT. Int. J. Radiat. Oncol. Biol. Phys. 66, S33\u2013S39 (2006).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"948_CR154","doi-asserted-by":"publisher","first-page":"678","DOI":"10.3171\/jns.2005.102.4.0678","volume":"102","author":"JP Sheehan","year":"2005","unstructured":"Sheehan, J. P. et al. Stereotactic radiosurgery for pituitary adenomas: an intermediate review of its safety, efficacy, and role in the neurosurgical treatment armamentarium. J. Neurosurg. 102, 678\u2013691 (2005).","journal-title":"J. Neurosurg."},{"key":"948_CR155","doi-asserted-by":"publisher","first-page":"446","DOI":"10.3171\/2013.3.JNS12766","volume":"119","author":"JP Sheehan","year":"2013","unstructured":"Sheehan, J. P. et al. Gamma Knife radiosurgery for the management of nonfunctioning pituitary adenomas: a multicenter study. J. Neurosurg. 119, 446\u2013456 (2013).","journal-title":"J. Neurosurg."},{"key":"948_CR156","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1227\/NEU.0b013e3182846e44","volume":"72","author":"Z Xu","year":"2013","unstructured":"Xu, Z., Lee Vance, M., Schlesinger, D. & Sheehan, J. P. Hypopituitarism after stereotactic radiosurgery for pituitary adenomas. Neurosurgery 72, 630\u2013637 (2013).","journal-title":"Neurosurgery"},{"key":"948_CR157","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/S0360-3016(98)00256-9","volume":"42","author":"M Mitsumori","year":"1998","unstructured":"Mitsumori, M. et al. Initial clinical results of LINAC-based stereotactic radiosurgery and stereotactic radiotherapy for pituitary adenomas. Int. J. Radiat. Oncol. Biol. Phys. 42, 573\u2013580 (1998).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"948_CR158","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1046\/j.1365-2265.2002.01570.x","volume":"57","author":"M Brada","year":"2002","unstructured":"Brada, M. et al. Cerebrovascular mortality in patients with pituitary adenoma. Clin. Endocrinol. 57, 713\u2013717 (2002).","journal-title":"Clin. Endocrinol."},{"key":"948_CR159","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.radonc.2012.04.024","volume":"104","author":"MG Sattler","year":"2012","unstructured":"Sattler, M. G. et al. The incidence of second tumours and mortality in pituitary adenoma patients treated with postoperative radiotherapy versus surgery alone. Radiother. Oncol. 104, 125\u2013130 (2012).","journal-title":"Radiother. Oncol."},{"key":"948_CR160","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/j.1365-2265.2005.02199.x","volume":"62","author":"G Minniti","year":"2005","unstructured":"Minniti, G. et al. The long-term efficacy of conventional radiotherapy in patients with GH-secreting pituitary adenomas. Clin. Endocrinol. 62, 210\u2013216 (2005).","journal-title":"Clin. Endocrinol."},{"key":"948_CR161","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1210\/jc.2016-3402","volume":"102","author":"P Burman","year":"2017","unstructured":"Burman, P., van Beek, A. P., Biller, B. M., Camacho-Hubner, C. & Mattsson, A. F. Radiotherapy, especially at young age, increases the risk for de novo brain tumors in patients treated for pituitary\/sellar lesions. J. Clin. Endocrinol. Metab. 102, 1051\u20131058 (2017).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"948_CR162","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1210\/jc.2018-01133","volume":"104","author":"AJ Swerdlow","year":"2019","unstructured":"Swerdlow, A. J. et al. Risk of meningioma in European patients treated with growth hormone in childhood: results from the SAGhE cohort. J. Clin. Endocrinol. Metab. 104, 658\u2013664 (2019).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"948_CR163","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1210\/jc.2016-2046","volume":"102","author":"AJ Swerdlow","year":"2017","unstructured":"Swerdlow, A. J. et al. Cancer risks in patients treated with growth hormone in childhood: the SAGhE European Cohort Study. J. Clin. Endocrinol. Metab. 102, 1661\u20131672 (2017).","journal-title":"J. Clin. Endocrinol. Metab."}],"container-title":["Nature Reviews Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41574-023-00948-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41574-023-00948-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41574-023-00948-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,16]],"date-time":"2024-04-16T15:27:46Z","timestamp":1713281266000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41574-023-00948-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,9]]},"references-count":163,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["948"],"URL":"https:\/\/doi.org\/10.1038\/s41574-023-00948-8","relation":{},"ISSN":["1759-5029","1759-5037"],"issn-type":[{"value":"1759-5029","type":"print"},{"value":"1759-5037","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,9]]},"assertion":[{"value":"19 December 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2024","order":3,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":4,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"In the version of the article initially published, an earlier, incorrect version of the Supplementary Information was posted. This has now been amended, and the correct Supplementary Information file now accompanies the online article.","order":5,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.K. received grant funding or served on the Advisory Board for Pfizer, Crinetics, Novo Nordisk, Recordati, and ONO Pharmaceuticals and honoraria from Ipsen, Corcept, Sandoz and Novo Nordisk. J.C.B. has received honoraria, funding and travel bursaries from Novo Nordisk and honoraria from Sandoz and Ipsen. J.H.D. has received travel bursaries from Sandoz, Pfizer, and Novo Nordisk and grant funding from Pfizer. T.S.J. is director and shareholder in Repath Ltd. and Neuropath Ltd. and received an honorarium from Bayer. H.L.S. received grant funding from Ipsen and Sandoz and consultancy fees from Novo Nordisk, Pfizer and Springer. H.A.S. has received honoraria from Ferring and Pfizer\u00a0and grants from Novo Nordisk and Sandoz. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}